Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Common Pain Med Ingredient May Treat Blood Cancers

Common Pain Med Ingredient May Treat Blood Cancers

September 30, 2025 Dr. Jennifer Chen Health

“`html





salicylic Acid Shows Promise in Blood Cancer Treatment


Salicylic Acid, Common in Skincare, Could‍ Treat ⁤Blood ‌Cancers

Share this
Article

You are free to share this article under​ the Attribution 4.0 International ⁢license.

Salicylic acid, a commonly used skincare and pain medication ingredient, could now also be used to treat‌ blood cancers, according to new research.

Two millennia after⁢ Hippocrates used willow bark⁤ to ease pain and fever, researchers at the Texas A&M University Health Science Center (Texas A&M Health) have transformed its key ingredient-salicylic acid-into a‍ molecular “remote control” that can turn therapeutic cell functions on or off.

In the new study, Yubin Zhou and Yun Huang‍ with the Texas A&M⁣ Health Institute of Biosciences and Technology used this technology-called Salicylic Acid-Mediated Binary Association (SAMBA)-to combat two common blood cancers:‍ acute lymphoblastic leukemia and B cell ‌lymphoma. Blood cancers account ⁣for‍ approximately 10% of new cancer diagnoses each year.

SAMBA uses⁢ salicylic acid, or aspirin, which is a ​cost-efficient and widely available drug for therapeutic use, making it a promising alternative to‌ more complex or expensive forms of cancer ‍immunotherapy.

Immunotherapy-which ‍uses the body’s​ own ⁢immune system to seek out and kill ⁤cancer cells-has been used as 1891 for bone cancer. But innovations like SAMBA are helping researchers make it safer and more effective.

SAMBA technology works by engineering CAR T cells so their cancer-killing activity can be turned on or off simply by giving or withholding⁤ salicylic acid, ⁢allowing doctors ⁣to precisely​ control when the treatment is active. ⁤In laboratory studies, ⁤SAMBA-equipped ​CAR T cells only destroyed cancer cells when salicylic acid was present. ​Stopping the salicylic acid “switch” caused the immune ​cells to pause their attack, ‍offering a new safety layer over traditional CAR T cell therapy.

“Much like playing‌ with a transformer toy,where you can quickly flip between a car and‍ a robot,we’re trying to ⁢recreate that quick switch so we can​ better…

At a Glance

  • What: Researchers have developed a method using salicylic acid (aspirin) to control CAR T-cell therapy for blood cancers.
  • where: ​Texas A&M University Health Science Center ​(Texas A&M Health).
  • When: ⁢Research published in [Insert Publication Date/Journal Here].
  • Why it matters: Offers a perhaps ‌safer and more controllable approach to cancer immunotherapy, utilizing a widely available and inexpensive drug.
  • What’s Next: Further research and clinical‍ trials are needed to assess the efficacy and safety of SAMBA in humans.

Editor’s Analysis

This ⁣research represents a significant step forward ⁣in refining CAR T-cell therapy. The ​ability ​to externally control the activity of‌ these engineered immune cells⁣ addresses a major safety concern – the potential for off-target effects and cytokine

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Blood, Cancer

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Copyright Notice
  • Disclaimer
  • Terms and Conditions

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service